Trigger point injections for myofascial pain in terminal cancer: a randomized trial
Pain Medicine · 01.01.2025 · 26 (1) · 14-21
DOI: 10.1093/pm/pnae084 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pain Medicine, online erschienen am 10.10.2024. Verfasst von Hideaki Hasuo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosomatic Medicine, Kansai Medical University, Osaka, Hirakata, Osaka, 573-1010, Japan. Hauptthemen laut MEDLINE: Anesthetics, Local, Lidocaine, Myofascial Pain Syndromes, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Grant for Research Advancement on Palliative Medicine, Japanese Society for Palliative Medicine.
Abstract (Originalsprache)
Objective
The aim of this study was to evaluate the efficacy and safety of a single trigger point injection (TPI) of a local anesthetic for the treatment of myofascial pain syndrome (MPS) in patients with incurable cancer.
Methods
This multicenter, exploratory, open-label, randomized comparative trial was conducted in five specialized palliative care departments. Hospitalized patients with incurable cancer who had been experiencing pain related to MPS were randomized to receive either a TPI of 1% lidocaine plus conventional care (TPI group) or conventional care alone (control group). The short-term efficacy and occurrence of adverse events (AEs) were compared between groups. The primary endpoint was the percentage of patients who experienced a reduction in pain scores of ≥50%, assessed using an 11-point Numerical Rating Scale, at 3 days post-intervention. Adverse events were assessed using the Common Terminology Criteria for AEs v5.0.
Results
Fifty patients were enrolled, and the trial completion rate was 100%. The proportion of patients who experienced an improvement in Numerical Rating Scale pain scores of ≥50% was 70.8% (95% confidence interval, 52.4%-89.2%) in the TPI group and 0.0% in the control group; the difference was statistically significant (P < .001). In the TPI group, one case (4.2%) of Grade 1 nausea and 1 case (4.2%) of Grade 1 somnolence were reported.
Conclusion
A single TPI of a local anesthetic is safe and efficacious in inducing an immediate reduction in MPS-related pain in patients with incurable cancer. Clinical trials registration number: This study was registered with the Japan Registry of Clinical Trials (approval number: jRCTs051210132) on December 16, 2021. https://jrct.niph.go.jp/en-latest-detail/jRCTs051210132. Approval of the research protocol by a Certified Review Board: The present study was approved by the Wakayama Medical University (reference number: CRB5180004. Registered 26 May 2021).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychosomatic Medicine, Kansai Medical University, Osaka, Hirakata, Osaka, 573-1010, Japan.
- Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
- Department of Psychosomatic Internal Medicine, NHO Kinki-Chuo Chest Medical Center, Sakai, 591-8555, Japan.
- Department of Psycho-Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
- Department of Palliative Medicine, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan.
- Department of Palliative Therapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, 135-0063, Japan.
ORCID-Profile: Hideaki Hasuo, Yoshinobu Matsuda, Hiromichi Matsuoka, Yoshihisa Matsumoto
Förderung
- Grant for Research Advancement on Palliative Medicine
- Japanese Society for Palliative Medicine
Zitieren
APA
Hasuo, H., Ishiki, H., Matsuda, Y., Matsuoka, H., Kosugi, K., Xing, M., Akiyama, Y., Matsumoto, Y., & Ishikawa, H. (2025). Trigger point injections for myofascial pain in terminal cancer: a randomized trial. Pain Medicine, 26(1), 14-21. https://doi.org/10.1093/pm/pnae084
Vancouver
Hasuo H, Ishiki H, Matsuda Y, Matsuoka H, Kosugi K, Xing M, et al. Trigger point injections for myofascial pain in terminal cancer: a randomized trial. Pain Medicine. 2025;26(1):14-21. doi:10.1093/pm/pnae084
BibTeX
@article{Hasuo2025,
author = {Hasuo, Hideaki and Ishiki, Hiroto and Matsuda, Yoshinobu and Matsuoka, Hiromichi and Kosugi, Kazuhiro and Xing, Mei and Akiyama, Yasushi and Matsumoto, Yoshihisa and Ishikawa, Hideki},
title = {Trigger point injections for myofascial pain in terminal cancer: a randomized trial},
journal = {Pain Medicine},
year = {2025},
volume = {26},
number = {1},
pages = {14--21},
doi = {10.1093/pm/pnae084}
}
EUVIMED